GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,982,000 | +87.9% | 350,000 | +75.0% | 0.68% | +254.7% |
| Q2 2018 | $9,040,000 | -6.4% | 200,000 | 0.0% | 0.19% | +58.7% |
| Q1 2018 | $9,660,000 | -29.9% | 200,000 | -42.9% | 0.12% | -41.8% |
| Q4 2017 | $13,773,000 | -19.4% | 350,000 | -36.4% | 0.21% | -29.3% |
| Q3 2017 | $17,078,000 | +78.4% | 550,000 | +57.1% | 0.29% | +76.0% |
| Q2 2017 | $9,573,000 | +48.4% | 350,000 | +100.0% | 0.17% | +16.8% |
| Q1 2017 | $6,449,000 | +81.4% | 175,000 | -28.9% | 0.14% | +81.0% |
| Q4 2016 | $3,555,000 | +54.2% | 246,054 | +146.1% | 0.08% | +71.7% |
| Q3 2016 | $2,305,000 | +11.1% | 100,000 | -20.0% | 0.05% | +7.0% |
| Q2 2016 | $2,074,000 | – | 125,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |